Truncating the amyloid cascade hypothesis: The role of C-terminal Aβ peptides in Alzheimer's disease

Neurobiology of Aging

Volumn 20, Issue 1, 1999, Pages 71-73

  Teplow, David B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; CARBOXY TERMINAL SEQUENCE; HUMAN; HYPOTHESIS; NOTE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; DOWN SYNDROME; HUMANS;

EID: 0032796179     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(99)00013-5     Document Type: Note

References (18)

1. Alzheimer A. Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde. Neurol Centr 1906;23:1129-36.
2. Busciglio J, Lorenzo A, Yeh J, Yankner BA. β-Amyloid fibrils induce tau phosphorylalion and loss of microtubule binding. Neuron 1995;14:879-88.
3. Citron M, Oltersdorf T, Haass C, et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 1992;360:672-4.
4. Citron M, Vigo-Pelfrey C, Teplow DB, et al. Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Nail Acad Sci USA 1994;91:11993-7.
5. Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997:56:321-39.
6. Geula C, Wu CK, Saroff D, Lorenzo A, Yuan ML, Yankner BA. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat Med 1998;4:827-31.
7. Haass C, Hung AY, Selkoe DJ, Teplow DB. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J Biol Chem 1994;269: 17741-8.
8. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;20:154-9.
9. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 1989;135:309-19.
10. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. Sequence of deposition of heterogeneous amyloid betapeptides and Apo E in Down syndrome-implications for initial events in amyloid plaque formation. Neurobiol Dis 1996:3:16-32.
11. Lemere CA, Khan K, Saido TC, et al. Temporal sequence of deposition of Aβ peptides bearing heterogeneous N-termini and Apo J in PD-APP transgenic mice. Soc. Neurosci 1997;23: 534 [209.5].
12. McKee AC, Kowall NW, Schumacher JS, Beal MR The neurotoxicity of amyloid beta protein in aged primates. Amyloid: Int J Exp Clin Invest 1998:5:1-9.
13. Pike CJ, Overman MJ, Cotman CW. Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro. J Biol Chem 1995; 270:23895-8.
14. N3(pE), in senile plaques. Neuron 1995;14:457-66.
15. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study [see comments]. N Engl J Med 1997;336:1216-22.
16. Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 1997;275:630-1.
17. Teplow DB. Structural and kinetic features of amyloid β-protein fibrillogenesis. Amyloid: Int J Exp Clin Invest 1998;5:121-42.
18. 693→Gln "Dutch" mutation on Aβ production and stability. Biochem J 1999; 340:703-9.